Evogene Ltd share price logo

Evogene Ltd Share Price

NASDAQ: EVGN

Small Cap

$0.72

-0.10

(-12.03%)

as on

Evogene Ltd Stock Performance

as on March 31, 2026 at 6:58 am IST

  • Day's High

    $0.72
    $0.80

    11.11%

    Upside

    downward going graph

  • 52 Week's High

    $0.72
    $2.42

    236.11%

    Upside

    downward going graph

Evogene Ltd share price movements today

Previous Close
$0.82
Open
$0.79
Volume
579.7K
Day's Low - High
$0.72 - $0.80
52 Week Low - High
$0.72 - $2.42

Evogene Ltd Historical Returns

1 Month Return
-13.29 %
3 Month Return
-33.2 %
1 Year Return
-41.22 %
3 Year Return
-88.34 %
5 Year Return
-98.54 %

Evogene Ltd Stock Fundamentals & Key Indicators

Check Evogene Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.5M

EPS (TTM)

-1.5

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-12.9M

Revenue (TTM)

3.9M

Profit Margin

-220.22%

Return On Equity TTM

-100.69%

Evogene Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evogene Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Evogene Ltd image
Evogene Ltd
BUY$7.5M-98.54%NA-220.22%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B123.88%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B106.23%28.2532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA115.055.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B58.37%17.7931.41%

Stock Returns calculator for Evogene Ltd Stock including INR - Dollar returns

The Evogene Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evogene Ltd investment value today

Current value as on today

₹63,829

Returns

-₹36,171

(-36.17%)

Returns from Evogene Ltd Stock

-₹42,400 (-42.4%)

Dollar Impact

₹6,229 (+6.23%)

Analyst Recommendation on Evogene Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evogene Ltd. Average target price of $1.75

Evogene Ltd Share Price Target

Get share price movements and forecasts by analysts on Evogene Ltd.

What analysts predicted

58.86%UPSIDE

Target Price

$1.75

Current Price

$0.72

Analyzed by

8 Analysts

Target

$1.75

Evogene Ltd target price $1.75, a slight upside of 58.86% compared to current price of $0.72. According to 8 analysts rating.

Evogene Ltd Stock’s Investor Sentiment and Interest

Search interest for Evogene Ltd Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Evogene Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3
0
4
0
1
1
2
0
0
0
Gross Profit
2
0
3
0
0
0
0
0
0
0
Operating Income
-4
-7
-3
-4
-5
-4
-4
-3
-2
-4
EBITDA
-3
-6
-3
-4
-3
0
-1
-2
-1
-4
Interest Expense
0
0
0
0
2
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-3
-7
-3
-4
-6
0
-2
-3
-2
-5
Income Tax Expense
0
0
0
0
0
0
-
0
0
-
Net Income
-3
-6
-3
-5
-7
0
-2
-4
3
-5
Net Profit Margin
-105.76%
-1142.04%
-92.20%
-895.70%
-438.51%
26.51%
-105.85%
-504.75%
1241.67%
-1690.76%

Evogene Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
3
1
0
1
0
1
5
8
3
Gross Profit
0
-1
-1
-2
-2
-2
-1
1
3
0
Operating Income
-21
-21
-21
-22
-26
-31
-29
-26
-21
-13
EBITDA
-17
-18
-18
-15
-23
-27
-26
-23
-15
-12
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
-
2
2
2
2
2
2
2
2
-
Income Before Tax
-19
-20
-20
-19
-26
-30
-29
-25
-18
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-19
-20
-20
-18
-23
-27
-26
-23
-16
-8
Net Profit Margin
-299.57%
-616.33%
-1188.21%
-2405.31%
-2247.50%
-2988.49%
-1590.33%
-423.39%
-193.69%
-220.22%

Evogene Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-3
-5
-8
0
-2
-3
-4
-5
Operating Cash Flow
-5
-4
-5
-4
-5
-5
-7
-3
-3
Investing Cash Flow
0
-4
3
2
8
-2
0
11
10
Financing Cash Flow
0
0
0
4
0
0
4
-10
0
Change in Cash
-6
-8
-2
1
3
-7
0
-2
7

Evogene Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-20
-19
-26
-30
-29
-25
-18
-14
Operating Cash Flow
-15
-15
-17
-19
-24
-23
-21
-19
-13
Investing Cash Flow
15
17
37
9
-20
13
-4
9
17
Financing Cash Flow
0
0
9
20
30
9
18
4
-6
Change in Cash
0
2
28
11
-13
-3
-8
-5
-2

Global Institutional Holdings in Evogene Ltd

Funds
Holdings
Federation des caisses Desjardins du Quebec
0.01%
JPMorgan Chase & Co
0%
Bank of America Corp
0%
Tradewinds Capital Management, LLC
0%
TWO SIGMA SECURITIES, LLC
0.13%
See all

Insights on Evogene Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 312.0K → 314.0K (in $), with an average increase of 0.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.4% return, outperforming this stock by 145.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 17.5% return, outperforming this stock by 52.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, EVGN stock has moved down by -87.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 3.87M → -5.30M (in $), with an average decrease of 237.0% per quarter

About Evogene Ltd

evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch
OrganisationEvogene Ltd
Headquarters13 Gad Feinstein Street, Rehovot, Israel, 7638517
IndustryHealth Technology
CEOMr. Ofer Haviv CPA
E-voting on sharesClick here to vote

Key Management of Evogene Ltd

Name

Title

Dr. Dan Jacob Gelvan Ph.D.

Chief Executive Officer of Ag Plenus Ltd.

Mr. Yaron Eldad

Chief Financial Officer

Dr. Ilia Zhidkov

Chief Technology Officer

Ms. Liat Foigel Wejgman

Vice President of Human Resources

Dr. Gabi Tarcic Ph.D.

Chief Development Officer

Ms. Polina Ravzin

Vice President of Finance

Mr. Ofer Haviv CPA

CEO, President & Director

Mr. Yoash Zohar

Chief Executive Officer of Casterra Ag Ltd.

FAQs

What is Evogene Ltd share price today?

Evogene Ltd share price today is $0.72 as on at the close of the market. Evogene Ltd share today touched a day high of $0.8 and a low of $0.72.

What is the 52 week high and 52 week low for Evogene Ltd share?

Evogene Ltd share touched a 52 week high of $2.42 on and a 52 week low of $0.72 on . Evogene Ltd stock price today i.e. is closed at $0.72,which is 70.25% down from its 52 week high and 0.00% up from its 52 week low.

What is Evogene Ltd's market capitalisation today?

Evogene Ltd market capitalisation is $0.00T as on .

How to invest in Evogene Ltd Stock (EVGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evogene Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evogene Ltd Shares that will get you 2.0833 shares as per Evogene Ltd share price of $0.72 per share as on March 31, 2026 at 1:28 am IST.

What is the minimum amount required to buy Evogene Ltd Stock (EVGN) from India?

Indian investors can start investing in Evogene Ltd (EVGN) shares with as little as ₹94.702 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Evogene Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Evogene Ltd share’s latest price of $0.72 as on March 31, 2026 at 1:28 am IST, you will get 13.8889 shares of Evogene Ltd. Learn more about fractional shares .

What are the returns that Evogene Ltd has given to Indian investors in the last 5 years?

Evogene Ltd stock has given -98.54% share price returns and 29.05% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?